BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 830791)

  • 1. Specific binding of soluble fibrin to macrophages.
    Sherman LA; Lee J
    J Exp Med; 1977 Jan; 145(1):76-85. PubMed ID: 830791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena.
    Colvin RB; Dvorak HF
    J Exp Med; 1975 Dec; 142(6):1377-90. PubMed ID: 1104745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
    Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.
    Veerhuis R; Van Es LA; Daha MR
    Eur J Immunol; 1985 Sep; 15(9):881-7. PubMed ID: 3876223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
    Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
    J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen/fibrin in atherogenesis.
    Smith EB; Thompson WD; Crosbie L; Stirk CM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of the reticuloendothelial system clearance of soluble fibrin.
    Sherman LA; Lee J; Jacobson A
    Br J Haematol; 1977 Oct; 37(2):231-8. PubMed ID: 603756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
    Shainoff JR; Stearns DJ; DiBello PM; Hishikawa-Itoh Y
    Thromb Haemost; 1990 Apr; 63(2):193-203. PubMed ID: 2163552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.
    Daha MR; Van Es LA
    Immunology; 1983 Sep; 50(1):107-11. PubMed ID: 6224740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
    Pozdniakova TM; Rybachuk VN; Vovk EV
    Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products.
    Rajagopalan S; Pizzo SV
    Blood; 1986 May; 67(5):1224-8. PubMed ID: 3008885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W; Delvos U; Müller-Berghaus G
    Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Participation of alveolar macrophages in the catabolism of fibrinogen and fibrin].
    Zubairov DM; Subkhankulova FB; Evranova GB
    Biull Eksp Biol Med; 1989 Mar; 107(3):335-7. PubMed ID: 2496767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ingestion and degradation of soluble immune complexes by guinea-pig macrophages and neutrophils.
    Leslie RG; Coupland K
    Immunology; 1985 Apr; 54(4):811-9. PubMed ID: 3980050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of soluble immune complexes of guinea pig IgG2 to homologous peritoneal macrophages. Determination of the avidity constants at 4 degrees C.
    Leslie RG
    Eur J Immunol; 1980 May; 10(5):317-22. PubMed ID: 7408934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes.
    Yakovlev S; Medved L
    Thromb Res; 2018 Feb; 162():93-100. PubMed ID: 29175090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.